Iris Alroy, PhD
Co-Founder and Chief Scientific Officer
Yoni Sheinberger, PhD
Head of Drug Discovery
Amanda Garner, PhD
Associate Professor of Medicinal Chemistry
University of Michigan
Broadcast Date: September 12, 2023
Time: 10:00 am PT, 1:00 pm ET, 19:00 CET
Recent progress in the development of high-content technologies for in-cell RNA visualization and imaging has revolutionized the exploration of mRNA biology and analysis of RNA-protein interactions. These technologies enable the investigation of complex cellular process networks through the selective localization and distribution of proteins and mRNAs between cell compartments, involving multiple regulators of translation such as RNA-binding proteins.
Join our upcoming webinar to hear from experts in the field, including Iris Alroy, Co-Founder and Chief Scientific Officer, Yoni Sheinberger, Head of Drug Discovery, both from Anima Biotech, a leading drug discovery platform company in the field of mRNA biology, and Amanda Garner, a world-renowned biologist, Associate Professor of Medicinal Chemistry and Director of the Interdepartmental Program in Medicinal Chemistry at the University of Michigan. Our experts will discuss the latest advancements in mRNA biology high-content technologies and their impact on drug discovery and research.
- Discover how recent advancements in high-content technologies for in-cell RNA visualization and imaging have revolutionized our understanding of mRNA biology and RNA-protein interactions, paving the way for groundbreaking discoveries.
- Explore the innovative applications of these cutting-edge technologies in unravelling the intricate networks of cellular processes, shedding light on the selective localization and distribution of proteins and mRNAs across different cell compartments.
- Gain valuable insights into the crucial role played by RNA-binding proteins and other regulators of translation in deciphering the dynamic and complex dynamics of cellular biology, opening new avenues for drug discovery and research.
A live Q&A session followed the presentation, offering a chance to pose questions to our expert panelists.
Produced with support from: